Some interesting suggestions William. I do agree with other posters who suggest that we are going to need a capital raise in the not too distant future if we don't do some sort of a deal but the company certainly seems to be focused on taking this to the clinic before any deals are done. I am basing that opinion on the response I got in relation to my inquiry on the manufacturing capabilities of the company -
"The Clinical roadmap ahead is both exciting and significant, meaning a considerable expansion and scale-up of current capacity is likely, as opposed to a contraction."
I wonder if company could ever scale up production to the extent that it becomes a supplier of heart valves to the market?
AVR Price at posting:
$23.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)